Cyclerion Therapeutics Statistics

Total Valuation

CYCN has a market cap or net worth of $10.21 million. The enterprise value is $6.57 million.

Market Cap	10.21M
Enterprise Value	6.57M

Important Dates

The last earnings date was Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CYCN has 3.21 million shares outstanding. The number of shares has increased by 4.80% in one year.

Current Share Class	3.21M
Shares Outstanding	3.21M
Shares Change (YoY)	+4.80%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	22.92%
Owned by Institutions (%)	16.31%
Float	2.31M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.87
Forward PS	n/a
PB Ratio	1.11
P/TBV Ratio	1.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.21

Current Ratio	4.21
Quick Ratio	3.96
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31.48% and return on invested capital (ROIC) is -23.17%.

Return on Equity (ROE)	-31.48%
Return on Assets (ROA)	-20.43%
Return on Invested Capital (ROIC)	-23.17%
Return on Capital Employed (ROCE)	-39.49%
Revenue Per Employee	$2.08M
Profits Per Employee	-$2.94M
Employee Count	1
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +11.55% in the last 52 weeks. The beta is 1.55, so CYCN's price volatility has been higher than the market average.

Beta (5Y)	1.55
52-Week Price Change	+11.55%
50-Day Moving Average	2.95
200-Day Moving Average	2.90
Relative Strength Index (RSI)	53.92
Average Volume (20 Days)	20,700

Short Selling Information

The latest short interest is 25,091, so 0.78% of the outstanding shares have been sold short.

Short Interest	25,091
Short Previous Month	52,070
Short % of Shares Out	0.78%
Short % of Float	1.09%
Short Ratio (days to cover)	1.68

Income Statement

In the last 12 months, CYCN had revenue of $2.08 million and -$2.94 million in losses. Loss per share was -$1.16.

Revenue	2.08M
Gross Profit	2.08M
Operating Income	-3.47M
Pretax Income	3.01M
Net Income	-2.94M
EBITDA	n/a
EBIT	-3.47M
Loss Per Share	-$1.16

Full Income Statement

Balance Sheet

The company has $3.64 million in cash and n/a in debt, giving a net cash position of $3.64 million or $1.13 per share.

Cash & Cash Equivalents	3.64M
Total Debt	n/a
Net Cash	3.64M
Net Cash Per Share	$1.13
Equity (Book Value)	8.78M
Book Value Per Share	2.87
Working Capital	3.43M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.43M
Capital Expenditures	n/a
Free Cash Flow	-3.43M
FCF Per Share	-$1.07

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -166.60% and -141.47%.

Gross Margin	100.00%
Operating Margin	-166.60%
Pretax Margin	-141.47%
Profit Margin	-141.47%
EBITDA Margin	n/a
EBIT Margin	-166.60%
FCF Margin	n/a

Dividends & Yields

CYCN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.80%
Shareholder Yield	-4.80%
Earnings Yield	-28.84%
FCF Yield	-33.60%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 16, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date	May 16, 2023
Split Type	Reverse
Split Ratio	0.05:1

Scores

CYCN has an Altman Z-Score of -34.68 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-34.68
Piotroski F-Score	1